Horizon Capital Invests in Viseven, Leading Global Pharma and Life Sciences MarTech Provider
Posted:
Horizon Capital, a U.S. private equity firm investing primarily in fast-growing tech and export-oriented businesses in Ukraine, announced an investment in Viseven, a leading global marketing tech provider servicing the pharma and life sciences industry. This transaction marks the third investment from its latest fund, Horizon Capital Growth Fund IV (HCGF IV), which reached $328 million at its most recent closing held in December 2023.
Upcoming Luscii - an OMRON Healthcare service webinar: Enabling Exceptional At-home Care for Children
Date: 12 September 2024, 10:30 – 11.15am
They explore the opportunities of technology-enabled paediatric care.
Sign up here.
S-PRO has become a member of SwissICT, the largest professional association for the Information and Communications Technology industry in Switzerland. Read the full article here.